Welcome to the Ethical Medicines Industry Group (EMIG)

The Ethical Medicines Industry Group (EMIG) was established in 1985 as the forum for small to medium-sized pharmaceutical companies operating in the UK. EMIG has grown substantially in recent years and now represents over 45 member companies.

EMIG's membership uniquely reflects the various stages of pharmaceutical company development in the UK, from start-ups whose prime focus is R&D, to highly developed businesses delivering essential products to patients while continuing to invest heavily in the fight against disease.

EMIG members employ c.6,000 people and have a turnover of £1bn.

They contribute significantly to the pharmaceutical sector and the British economy. Data from IMS, a leading provider of health data, shows that:

• 90% of UK  pharmaceutical companies achieve annual gross sales of under £50m.
• These companies contribute essential products to the NHS and considerably less to the NHS drugs bill.
• In 2006, “small” pharmaceutical companies provided 40% of products, yet only accounted for 10% of the NHS drugs bill

If you are involved in running or managing a company developing or selling medicines to the NHS and wish to expand your contact base, as well as influence the policy that affects your business, then you may wish to consider joining EMIG or contacting the EMIG Coordinator.